Kraft Heinz: A Value Investing Deep Dive

The recurring and predictable nature of revenue is solid overall. It sells high-frequency consumer goods, does not depend on one-off large orders, and does not hinge on a particular software release, blockbuster drug, or cyclical megaproject; the company also explicitly states that business seasonality generally has no material impact at the consolidated level. At the same time, "predictable" does not mean "growing": in 2025, net sales fell from $25.846 billion to $24.942 billion, with Organic Net Sales down 3.4%, mainly a 4.1 percentage point drag from volume/mix that a 0.7 percentage point price increase could only partly offset; Q1 2026 was still the familiar combination of "price up, volume/mix down." In other words, the demand base is stable, but the brand's share and consumer stickiness are not entirely intact.

The cost structure is also typical: upstream it must buy large volumes of agricultural commodities and packaging materials, including dairy, meat, sugar, coffee, tomatoes, vegetable oils, cartons, glass, metal, and plastic resin, plus energy; in the middle there is manufacturing, warehousing, and logistics; downstream it needs ongoing marketing and promotional spending. In its 2025 annual report, the company states plainly that input and manufacturing cost inflation, tariffs and trade policy, and supply chain cost pressure all erode profit, and its main responses are efficiency improvements, price increases, alternative sourcing, and hedging. This shows it is not the ideal "asset-light, subscription-fee, very strong user lock-in" model, but a low-capex packaged-food business that is still deeply affected by commodity costs and channel bargaining.

If the stock market were turned off for five years, would I be willing to own this business? Yes, but only on a very clear rationale: I would be holding a food asset that keeps producing cash, pays a high dividend, and is not expensively valued, not a super-brand compounding machine with a continuously widening moat. This matters, because it sets both the valuation framework and the position-size cap. Business understandability score: 4.5/5.

Industry and competitive landscape. The packaged food industry as a whole looks more like a mature industry: long-term demand is stable, but growth is usually low, and category shifts, health trends, retailer private label, channel concentration, and consumer price sensitivity continuously reshape how profit is distributed. In its own 10-K risk factors, Kraft Heinz explicitly states that industry competition comes from both branded players and retailer private label, that competition spans price, innovation, quality, nutrition, service, marketing efficiency, and distribution capability, and it also flags that retailer concentration, shifting consumer preferences, and e-commerce/mobile commerce reshaping the retail landscape could all harm its sales and profit.

The main comparable peers broadly include General Mills, Conagra, Campbell's, and J.M. Smucker. The current market's native GAAP P/E for these companies is not fully comparable, because the industry carries many impairments and one-off items: as of May 22, 2026, GIS trades at about 8.2x P/E and CPB at about 10.9x, while the GAAP P/E of CAG and SJM is distorted by disrupted earnings; KHC's GAAP P/E has even turned negative because of the large 2025 impairments. In this industry, free cash flow, adjusted earnings, and whether the brands can hold volume matter far more than GAAP P/E.

KHC's position in the industry is that of a large player that is "high-volume, brand-rich, deeply rooted in North America, broadly distributed globally, but weak on growth." It is neither a collection of cutting-edge high-growth brands nor a platform business with network effects. If I had to define it, I lean toward: it is "a large cash-flow company in an ordinary industry," not "a top company in a good industry." Industry attractiveness score: 2.5/5.

Moat and Management

Moat analysis. Brand strength is KHC's most genuine and most central moat. The company owns a series of highly recognizable brands, and in both 2025 and Q1 2026 it was still able to push price increases across segments, showing the brand mindshare has not disappeared, especially in condiments, parts of cheese, and convenient meals where brand still matters. The issue is that this moat does not look "wide and deep" the way Coca-Cola's does; it looks more like "the width is still there, but the edges are being eroded": in 2025, company-wide price rose 0.7 percentage points while volume/mix fell 4.1 percentage points; in Q1 2026, price again rose 0.8 percentage points while volume/mix fell 1.2 percentage points. This shows the brand can still raise price, but consumers do not accept it unconditionally.

Cost and scale advantages are the second layer of the moat. The company has 69 manufacturing and processing facilities and leverages scale through centralized procurement of bulk inputs, giving it a real edge in manufacturing, sourcing, and distribution efficiency. Unfortunately, scale is not enough to translate automatically into very strong pricing power, because retailers are also very strong and differentiation in packaged food is not high enough to insulate it from competition. Put differently, KHC's scale is more a "defensive tool" than an "offensive weapon."

Channel advantage exists but is constrained by retailer strength. Being able to get into top channels like Walmart is itself an advantage, but because Walmart alone accounts for 21% of sales, this channel advantage embeds channel dependence at the same time. Network effects, switching costs, data advantage, patents, and regulatory barriers are mostly not core to this business. A consumer switching from one ketchup to another faces low switching costs despite taste habits, and patents are not a key source of profit.

The high margins of the past were largely not the result of a purely structural moat, but of "brand plus scale plus cost control" working together; and the large 2025 impairments — including Kraft, Velveeta, Lunchables, and Maxwell House — are precisely a reminder that even well-known brands can see their economic value shrink as growth expectations, price elasticity, and long-term cash flow are revised down. In my judgment, KHC's moat status is: still present, but on balance "stable to slightly narrowing," rather than widening. Moat strength score: 2.5/5.

Management and capital allocation. First the positives. In recent years, the company has not blindly expanded its balance sheet but has kept paying dividends, repurchased shares moderately, and overall reduced debt from $28.3 billion at year-end 2020 to roughly $19.9 billion at year-end 2024, though it rose back to about $21.2 billion in 2025 due to refinancing and new issuance. This suggests recent financial discipline is more balanced than the "3G-era relentless cost-cutting" narrative. The company has held its common dividend at $1.60 per share for the past three years, with 2025 and 2026 dividends still supported by free cash flow and operating cash flow.

But the capital allocation history cannot be glossed over. The original Kraft Heinz merger itself did not create sustained high-quality growth; over many years it instead paid the price for underinvesting in brands, aging categories, shifting consumer tastes, and overvalued assets. The current management was not entirely responsible for that merger, but within the board and shareholder structure, Berkshire still holds about 27.3% of equity; meanwhile, in 2025 the company first announced a plan to split into two listed companies via a tax-free spin-off, then in February 2026 announced a pause on that work, which shows the strategic direction still carries a trial-and-error flavor today.

Management ownership is not high. Per the 2025 proxy, current directors and executives together held about 4.15 million shares, less than 1% of total shares outstanding; then-CEO Carlos Abrams-Rivera held about 528,000 shares, far from "taking on risk alongside all shareholders with a heavy stake." On the positive side, the company strengthened executive ownership requirements, raising the CEO's requirement to 6x base salary; on the negative side, the actual degree of equity alignment remains modest. For a company one hopes to hold on long-term investment logic, this is not a plus.

My overall assessment of management is: more pragmatic than the aggressive cost-focused phase of the past, but not yet proven as an outstanding capital allocator. The recent move to bring in new CEO Steve Cahillane, propose $600 million of added commercial investment, and emphasize market share recovery is directionally more reasonable than simply squeezing profit; but whether that "investment translates into long-term incremental value" is far from proven. Management and capital allocation score: 2.5/5.

Financial Quality and Owner Earnings

Key financial metrics.

The table below is compiled from the company's 10-K/10-Q and current price. 2020–2021 figures are mainly drawn from retrieved snippets of the 2021/2022 10-K; 2022–2025 mainly from the 2024/2025 10-K. "Free cash flow" is roughly estimated as operating cash flow minus capital expenditures.

This table tells me three things. First, revenue has no long-term upward trend and has basically drifted down since the pandemic peak. Second, cash flow quality is clearly better than the net-income optics suggest, especially in 2025, where despite a huge GAAP loss, OCF was still $4.462 billion. Third, capital expenditure intensity is not high, running at roughly 3%–4% of sales in recent years, which is one of the most attractive features of this business for a long-term owner.

On margins, the 2025 GAAP picture is very ugly: net sales $24.942 billion, operating loss $4.669 billion, net loss $5.848 billion; but this includes $9.306 billion of goodwill and intangible impairments. Excluding those, 2025 adjusted operating profit was $4.745 billion, an adjusted operating margin of about 19.0%, below 2024's 20.7%; Q1 2026 adjusted operating profit was $1.058 billion, an adjusted operating margin of about 17.5%, still trending down. In other words, the underlying earnings power is still there, but the direction is not improving — it is under pressure.

On operating quality, the increase in 2025 operating cash flow came mainly from inventory optimization, tax-timing changes, lower cash incentive payouts, and the conversion of pension-related assets into cash; the Q1 2026 improvement in operating cash flow came mainly from inventory optimization, better supplier payment terms, and derivative-margin-related changes. Caution is required here: these are all real cash flows, but they should not all be treated as permanent cash flow. In particular, the company disclosed in 2025 that the One Big Beautiful Bill Act affected the timing of cash tax payments; meanwhile, the conversion of U.S. postretirement medical plan assets into cash also helped OCF.

The balance sheet is not fragile, but it is not exactly comfortable either. At the end of Q1 2026, the company had cash and cash equivalents of $3.308 billion and marketable securities of $0.783 billion, together close to $4.09 billion; total debt was about $21.1 billion and net debt about $17.0 billion. On a rough 2025 adjusted EBITDA basis (adjusted operating profit $4.745 billion plus depreciation and amortization $0.968 billion), net debt to adjusted EBITDA is around 3x, a level that is manageable but should not be taken lightly. 2025 interest expense was $0.947 billion, and if covered by adjusted operating profit, interest coverage is about 5x. This is enough to survive, but not exactly traveling light.

On working capital, in 2025 receivables fell $55 million, inventory released $133 million, payables decreased $97 million, and other current liabilities rose $337 million, for a net favorable effect; but the supplier financing program balance remained at $755–756 million, showing the company optimizes cash flow to some degree through payment timing. For long-term shareholders this is not a bad thing, but one should avoid mistaking "payment-timing optimization" for "a permanent improvement in operating quality."

Are the profits real cash profits, or accounting profits? My judgment is: the 2025 GAAP profit clearly understates the true cash earnings power, but the large impairments cannot be treated as "completely irrelevant." Because while impairments do not consume cash, they reflect overly optimistic assumptions about past acquisitions and brand value, meaning the very capability for future high returns has been re-rated. Put differently, the cash profit is real, and the impairment also has economic meaning.

Signs of financial fraud, aggressive accounting, or earnings manipulation. Looking at the latest annual report and latest quarterly report themselves, I do not see disclosed signs of major unresolved internal control failures; but I am particularly wary of the ongoing sensitivity of brand valuation and goodwill impairment, because in Q2 2025 the company triggered an interim impairment test precisely because of a continued decline in share price and market cap, and acknowledged that several brand values had fallen. The bigger risk here is not "disguising cash as profit" but "having valued brands too highly in the past and continuing to revise them down in the future."

Valuation and Margin of Safety

Owner earnings analysis. In Buffett-style thinking, I care more about "the true distributable cash to shareholders." Starting directly from net income, the 2025 net loss of $5.848 billion would lead to a completely wrong conclusion, because it includes $9.306 billion of non-cash goodwill and brand impairments. Switching to a cash-flow approach: 2025 operating cash flow was $4.462 billion, capital expenditures $0.801 billion, and reported free cash flow about $3.661 billion; but this includes pension-related cash inflows and tax-timing benefits, so I would conservatively deduct $300–500 million of one-off/timing help, putting a more reasonable normalized owner earnings at roughly $3.2–3.4 billion. On a Q1 2026 rolling basis, unadjusted TTM FCF is even close to $3.9 billion, but I will not directly adopt that more optimistic number.

At the current market cap of $27.9 billion, KHC trades at about 8.2–8.7x my conservative owner earnings, an owner earnings yield of roughly 11.5%–12.2%. Looking at the dividend alone, the annual dividend of $1.60 per share corresponds to a dividend yield of about 6.8% at the current price. This valuation is not expensive — it could even be said to carry "problem pricing." But the key for this stock is whether the "E" in owner earnings is stable.

Method 1: Discounted owner earnings. My core assumptions are: starting owner earnings of $3.3 billion; a discount rate in the 8.5%–10.0% range, referencing the current U.S. 10-year Treasury risk-free yield of about 4.57% plus an added premium for consumer-business, brand-decline, and leverage risk. The terminal growth rate is low, because this is not a high-growth business.

I lay out three scenarios. Conservative scenario: owner earnings essentially zero growth over the next 10 years, a 10% discount rate, and 0% terminal growth, implying equity value of roughly $34 billion, or about $29 per share; if I leave a little room for continued brand markdowns and working-capital give-back, the conservative range can be seen as $24–29 per share. Base scenario: owner earnings grow 1%–1.5% per year over the next 10 years, a 9% discount rate, and 1% terminal growth, implying about $32–37 per share. Optimistic scenario: if the added 2026–2027 spending genuinely brings share recovery and owner earnings return to 2%–3% annual growth, with an 8.5% discount rate and 1.5%–2% terminal growth, value could reach $38–48 per share. None of these are "precise answers"; they are reasonable ranges centered on the stability of cash flow.

Method 2: Relative valuation. GAAP P/E is not very useful in this industry: KHC and several peers are all distorted by impairments, tax items, and one-off charges. More meaningful is: KHC's current price equals about 11.2–11.9x the midpoint of the company's 2026 adjusted EPS guidance ($1.98–2.10), about 9.1x 2025 adjusted EPS of $2.60; at the same time about 7.6x 2025 free cash flow and about 7.8x my rough net-debt-basis EV/adjusted EBITDA. By comparison, GIS currently trades at about 8.2x native P/E and CPB at about 10.9x, while the GAAP P/E of CAG and SJM is again distorted by disrupted earnings. My conclusion is not "KHC is absolutely cheaper than peers," but rather: among "problem stocks" it is not expensive, yet the cheapness itself reflects its growth and moat issues.

Method 3: Asset or liquidation value. On a hard-asset liquidation view, this company is not cheap. At the end of 2025, total assets were $81.786 billion, of which goodwill was $22.179 billion and intangibles $37.529 billion, together close to $59.7 billion; total liabilities were $39.997 billion. In other words, what truly supports the equity value is not hard assets but the brands and their future cash flows. Stripping out goodwill and the vast majority of intangibles, KHC's tangible net worth does not provide a strong cushion. So the asset approach can only tell us: this is not a "bankruptcy-liquidation" undervaluation but a "going-concern cash-flow" valuation.

Intrinsic value range and price bands. Combining the three methods, the range I arrive at is:

• Conservative intrinsic value range: $24–29 per share

• Fair intrinsic value range: $30–37 per share

• Optimistic intrinsic value range: $38–48 per share

At the current $23.54 per share, there is only a small discount to conservative value and a moderate discount to fair value. My conclusion is: a margin of safety exists, but it comes mainly from "low price plus high cash returns," not from "very high business quality." For this kind of company, the position discipline I want is:

• Ideal buy price range: $20–24

• Acceptable holding price range: $24–32

• Clearly overvalued range: above $38 All these price bands are built on the premise that "owner earnings broadly hold up."

Is the margin of safety adequate? If you treat KHC as a "high-certainty consumer leader," then the margin of safety at the current price is not thick enough; if you treat it as a "low-growth, defensive, strong-cash-flow, still-has-turnaround-upside out-of-favor food stock," then the current price can be considered to carry some margin of safety. The most fragile assumption in the valuation is not the discount rate but whether volume/mix can stabilize. If the truth of 2026–2027 turns out to be "after spending an extra $600 million, volume still keeps shrinking and the adjusted operating margin falls below 16% over the long run," then a stock that looks like 8x owner earnings today may not be so cheap after all.

Risks, Comparisons, and Checklist

The most important risks and the strongest bear case. The strongest bear case is actually simple: KHC is not undervalued — it is a value trap. The reasons include: first, the brands are slowly aging, as consumers become more health-conscious, more fragmented, and more price-sensitive, and traditional big brands appeal less to younger consumers; second, stronger retailer private label and top-channel power mean its pricing ability increasingly comes at the cost of volume; third, the large 2025 impairments are not incidental accounting noise but a clear signal of brand assets' economic value being revised down; fourth, management first proposing a spin-off and then pausing it shows the strategic direction is not very clear; fifth, if operating improvement over the next two to three years falls short, the market may keep pricing it as a "high-dividend, low-growth, slowly declining" stock.

Specific risks include: competition risk and channel risk, especially Walmart's 21% share; shifts in consumer preferences and changes in technology/marketing methods; regulatory and formula changes, such as removing FD&C colors and SNAP policy adjustments; supply-chain and commodity-cost volatility; debt and interest-rate risk; currency volatility; and most importantly the brand valuation risk — if future operating assumptions continue to be revised down, the company could still take further significant impairments. The biggest permanent capital-loss scenario is: volume keeps falling, margins contract, brands take further impairments, the dividend is forced to be adjusted, the valuation slides from "cheap cash cow" to "chronic decliner," and the share price drops into the high-teens over the medium-to-long term.

What facts would overturn the investment judgment? If the following facts emerge in the future, I would admit the current "Cautious Buy" judgment is wrong: First, the added 2026–2027 spending fails to improve Organic volume/mix, and volume/mix even deteriorates to -2% per year or worse; Second, the adjusted operating margin keeps falling below 16%–17% with no sign of stabilizing; Third, net debt to adjusted EBITDA clearly rises above 3.5x while the dividend starts to depend on borrowing; Fourth, another large impairment hits core brands, especially Heinz, Kraft, and Philadelphia — the brands that "should be the most resilient"; Fifth, management keeps wavering on strategic path, spin-off, and capital allocation.

Comparison with indices, bonds, and other opportunities. Compared with the S&P 500, KHC's advantage is a clearly higher current cash return: a dividend yield of about 6.8% and a conservative owner earnings yield above 11%; but its disadvantages are slow growth, high brand risk, and single-business risk far above the index. Compared with the U.S. 10-year Treasury yield of about 4.57%, KHC appears to offer a higher current cash return and some upside, but you are taking on operating risk, brand risk, and management-execution risk rather than a risk-free coupon. My conclusion is: KHC is more attractive than comparable bonds for a certain kind of value/income capital, but for most ordinary investors it is not clearly superior to buying the index. If your portfolio could hold only five assets, I generally would not put KHC among the "five most core long-term compounding assets," unless your portfolio explicitly needs one high-dividend, low-valuation, consumer-defensive position.

Investment checklist. The judgments below are an integrated conclusion based on the financial, risk, and valuation facts above.

Open questions and limitations. Three points still need ongoing verification. First, the company does not clearly disclose a strict split between maintenance capex and growth capex, so owner earnings carries an estimation component. Second, making adjusted EV/EBITDA and adjusted P/E fully comparable across peers would require stripping out impairments, tax items, and merger factors company by company; this report therefore emphasizes KHC's absolute valuation and directional comparison more. Third, on the execution quality after the new CEO took over in 2026, the evidence is still very early, and whether market share recovery holds will require several more quarters of data to verify.

Final Investment Conclusion

【Final rating】 Cautious Buy

【One-sentence investment thesis】 Kraft Heinz is not a great compounding machine, but at the current price of about $23.54, it already looks like an "undervalued consumer stock with high cash flow, low growth, and a turnaround option," suited to a small-to-moderate, patient long-term position rather than a top-weight core holding.

【Core bull case】 The business is simple and the demand base is stable; capital expenditures are low and free cash flow is substantial over the long run; the current dividend yield of about 6.8% is attractive to income capital; on a conservative basis, owner earnings valuation is not high; and the added brand and sales spending from 2026 onward, if it brings share improvement, leaves room for a valuation re-rating.

【Core bear case】 The brand moat is not solid, and recent price increases have often come with declining volume/mix; the $9.306 billion of large impairments in 2025 shows brand asset value being re-rated; channel power is large, with Walmart at about 21% of sales; management's strategic path went through "spin-off, then pause the spin-off"; and this company looks more like a "cheap cash-flow machine" than a "high-quality long-term compounder."

【Key assumptions】 For the investment to hold, the following must be met: the renewed 2026–2027 spending at least stabilizes Organic volume/mix; the adjusted operating margin holds at the mid-to-high teens; free cash flow does not fall clearly below $3.0 billion because of tax/working-capital give-back; net leverage does not rise into a dangerous range; and brand impairments stop repeatedly eroding long-term confidence.

【Fair buy price】 I think a more comfortable entry is $20–24; the current $23.54 sits in the "you can start buying, but do not overweight impulsively" zone. The basis: conservative value is about $24–29, fair value about $30–37, and the current price carries a discount to the base value but only a shallow discount to the conservative value.

【Target holding period】 At least 3–5 years to verify whether the 2026–2027 reinvestment works; if you only intend to play an earnings rebound over a quarter or two, this is not an ideal name.

【Expected annualized return】 Estimating from the current price, my subjective ranges are: conservative scenario 4%–7%, mainly from the dividend and limited valuation re-rating; base scenario 8%–11%, from the dividend, limited growth, and valuation mean-reversion; optimistic scenario 11%–14%, premised on stabilizing share, recovering margins, and the market re-rating it closer to fair value. This is not a promised return but a scenario estimate based on owner earnings, the dividend, and the valuation range.

【Maximum loss risk】 If this is in fact a "chronically declining packaged-food stock" rather than a "repairable cash cow," then with continued volume decline, further margin compression, another impairment, and lower dividend expectations, a medium-to-long-term drop to $16–19 is not far-fetched, implying roughly 20%–30% permanent capital-loss risk relative to the current price.

【Tracking metrics】 The things most worth tracking going forward are: Organic Net Sales; volume/mix; adjusted operating margin; free cash flow and free-cash-flow conversion; net debt to adjusted EBITDA; shipment trends at large customers like Walmart; whether core brands take further impairments; market-share changes after marketing spending; dividend coverage; and the price and pace of buyback execution.

【Signals that trigger a re-evaluation】 If any of the following occur, I would immediately re-examine the logic: clearly negative volume/mix over several consecutive quarters; management building the high dividend on borrowing or working-capital overdraw; another large impairment of core brands; a marked rise in net leverage; reinvestment yielding no share improvement at all; or another major swing in strategic direction.

【Final recommendation】 If you are a balanced-to-conservative long-term investor, my recommendation is not "all in" but: treat KHC as a defensive value stock whose valuation is starting to look attractive, allow a small-to-moderate position bought in tranches, but do not mistake it for a top-tier consumer compounding asset. It is worth researching and worth participating in at the right price; but it is more of an "ordinary good company with cash flow, dividends, and turnaround room" than "a great business you can hold for ten years with your eyes closed, never worrying about its competitive position." In a true long-term portfolio, that distinction matters a great deal.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.